KISCO Corp
KRX:104700
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
6 240
12 600
|
Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
KISCO Corp
Current Assets | 687.5B |
Cash & Short-Term Investments | 507.3B |
Receivables | 104.2B |
Other Current Assets | 76.1B |
Non-Current Assets | 284.9B |
Long-Term Investments | 20.1B |
PP&E | 257.7B |
Intangibles | 362.8m |
Other Non-Current Assets | 6.7B |
Current Liabilities | 84.3B |
Accounts Payable | 38.9B |
Accrued Liabilities | 5.8B |
Other Current Liabilities | 39.6B |
Non-Current Liabilities | 36.4B |
Long-Term Debt | 55.1m |
Other Non-Current Liabilities | 36.3B |
Balance Sheet
KISCO Corp
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
49 325
|
44 254
|
75 658
|
116 729
|
123 437
|
102 664
|
68 349
|
7 461
|
20 613
|
30 447
|
|
Cash |
2
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Cash Equivalents |
49 323
|
44 253
|
75 658
|
116 729
|
123 436
|
102 663
|
68 348
|
7 460
|
20 612
|
30 446
|
|
Short-Term Investments |
98 153
|
161 995
|
186 372
|
236 409
|
263 267
|
272 231
|
367 756
|
407 315
|
424 361
|
476 851
|
|
Total Receivables |
162 208
|
153 530
|
152 759
|
147 015
|
142 771
|
115 902
|
89 698
|
117 116
|
123 990
|
104 196
|
|
Accounts Receivables |
161 465
|
153 278
|
152 638
|
146 902
|
142 585
|
115 485
|
89 573
|
116 866
|
123 855
|
104 113
|
|
Other Receivables |
743
|
252
|
121
|
113
|
186
|
417
|
125
|
249
|
135
|
83
|
|
Inventory |
115 814
|
75 648
|
77 231
|
82 243
|
82 799
|
81 323
|
50 330
|
80 146
|
67 682
|
75 703
|
|
Other Current Assets |
295
|
174
|
183
|
163
|
90
|
231
|
151
|
166
|
13 580
|
350
|
|
Total Current Assets |
425 795
|
435 601
|
492 204
|
582 559
|
612 363
|
572 351
|
576 286
|
612 203
|
650 225
|
687 547
|
|
PP&E Net |
423 701
|
425 012
|
409 431
|
275 891
|
273 514
|
278 834
|
273 610
|
272 777
|
262 201
|
257 732
|
|
PP&E Gross |
423 701
|
425 012
|
409 431
|
275 891
|
273 514
|
278 834
|
273 610
|
272 777
|
262 201
|
257 732
|
|
Accumulated Depreciation |
367 350
|
391 434
|
377 627
|
516 201
|
531 919
|
546 248
|
552
|
504 163
|
411 226
|
414 968
|
|
Intangible Assets |
917
|
917
|
917
|
1 459
|
772
|
56
|
56
|
56
|
56
|
363
|
|
Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Long-Term Investments |
50 748
|
34 277
|
38 966
|
25 710
|
21 813
|
21 294
|
18 236
|
23 133
|
20 692
|
20 129
|
|
Other Long-Term Assets |
790
|
770
|
249
|
262
|
576
|
681
|
588
|
538
|
15 374
|
6 693
|
|
Total Assets |
901 950
N/A
|
896 578
-1%
|
941 767
+5%
|
885 882
-6%
|
909 037
+3%
|
873 217
-4%
|
868 775
-1%
|
908 707
+5%
|
948 549
+4%
|
972 464
+3%
|
|
Liabilities | |||||||||||
Accounts Payable |
130 006
|
85 600
|
93 064
|
118 020
|
119 400
|
79 307
|
62 183
|
119 089
|
40 643
|
38 919
|
|
Accrued Liabilities |
3 737
|
6 508
|
5 698
|
4 590
|
4 364
|
6 358
|
5 088
|
5 352
|
8 703
|
5 771
|
|
Short-Term Debt |
13 165
|
0
|
0
|
0
|
0
|
11 584
|
1 978
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
50
|
23
|
44
|
65
|
60
|
|
Other Current Liabilities |
35 433
|
39 875
|
32 821
|
32 719
|
54 008
|
31 477
|
85 663
|
41 749
|
80 173
|
39 566
|
|
Total Current Liabilities |
182 341
|
131 982
|
131 583
|
155 329
|
177 771
|
128 776
|
154 935
|
166 234
|
129 584
|
84 316
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
10
|
26
|
42
|
31
|
55
|
|
Deferred Income Tax |
11 820
|
21 196
|
33 469
|
9 971
|
11 532
|
8 636
|
10 532
|
12 727
|
18 523
|
7 928
|
|
Other Liabilities |
16 960
|
14 583
|
7 767
|
2 301
|
2 483
|
10 858
|
6 451
|
7 516
|
1 882
|
28 418
|
|
Total Liabilities |
211 121
N/A
|
167 761
-21%
|
172 819
+3%
|
167 601
-3%
|
191 787
+14%
|
148 280
-23%
|
171 945
+16%
|
186 519
+8%
|
150 021
-20%
|
120 717
-20%
|
|
Equity | |||||||||||
Common Stock |
46 050
|
46 050
|
46 050
|
46 050
|
46 050
|
46 050
|
46 050
|
46 050
|
46 050
|
46 050
|
|
Retained Earnings |
83 773
|
127 775
|
167 914
|
117 063
|
118 717
|
125 974
|
106 021
|
185 832
|
232 696
|
285 637
|
|
Additional Paid In Capital |
552 548
|
552 548
|
552 548
|
552 548
|
552 548
|
552 548
|
552 548
|
552 548
|
552 548
|
552 548
|
|
Unrealized Security Profit/Loss |
8 619
|
2 605
|
2 597
|
2 781
|
97
|
526
|
1 804
|
1 182
|
942
|
664
|
|
Treasury Stock |
162
|
162
|
162
|
162
|
162
|
162
|
5 985
|
63 424
|
31 824
|
31 824
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
690 829
N/A
|
728 816
+5%
|
768 948
+6%
|
718 281
-7%
|
717 250
0%
|
724 937
+1%
|
696 831
-4%
|
722 188
+4%
|
798 528
+11%
|
851 748
+7%
|
|
Total Liabilities & Equity |
901 950
N/A
|
896 578
-1%
|
941 767
+5%
|
885 882
-6%
|
909 037
+3%
|
873 217
-4%
|
868 775
-1%
|
908 707
+5%
|
948 549
+4%
|
972 464
+3%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
46
|
46
|
46
|
46
|
46
|
46
|
45
|
39
|
39
|
39
|